Urine test may outsmart blood test for kidney rejection
NCT ID NCT07415876
First seen Jun 25, 2026 · Last updated Jul 16, 2026 · Updated 3 times
Summary
This study tests whether a urine test for a protein called CXCL10 can catch kidney transplant rejection that a standard blood test misses. Researchers will compare the urine test to biopsy results in 50 kidney transplant patients. They will also check if the urine samples can be shipped at room temperature without affecting accuracy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- urinary CXCL10 test
- What this could lead to
- If successful, this could lead to a more accurate, non-invasive urine test for kidney transplant rejection, reducing the need for biopsies.
- What could go wrong
- This is a small, early-stage study (50 participants) focused on diagnostic accuracy, not treatment. The test may not prove reliable enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your gut bacteria change how transplant drugs work?
- Your gut bacteria might predict transplant rejection
- Engineered immune cells aim to trick the body into accepting a new kidney
- Massive data dive aims to outsmart kidney transplant rejection
- Smartphone Check-Ins could save transplanted kidneys
- Harmless virus levels may predict transplant complications